drugset / Trial / NCT02353299

Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers

NCT02353299

RandomizedCrossoverDouble-blindDiagnostic

Summary

This is a Phase IV, randomized, double-blind, placebo-controlled, four-arm crossover study. The study will assess the effects of a single dose of Silenor 6 mg compared with matching placebo and a single dose of zolpidem 10 mg compared to its matching placebo at the respective T-max in normal healthy adult male volunteers. The study will be conducted in approximately 52 male subjects

Timeline

Start
2015-01
Primary completion
2016-01
Completion
2016-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxepin Unknown 6 mg
Comparator Zolpidem Small molecule 10 mg Oral

Indications

No indication recorded.